Panagora Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,303
Closed -$665K 1731
2021
Q3
$665K Sell
7,303
-5,763
-44% -$490K ﹤0.01% 1169
2021
Q2
$821K Buy
13,066
+1,454
+13% +$53.8K ﹤0.01% 1093
2021
Q1
$315K Buy
11,612
+10,998
+1,791% +$265K ﹤0.01% 1546
2020
Q4
$11K Sell
614
-2,896
-83% -$52.1K ﹤0.01% 2284
2020
Q3
$63K Hold
3,510
﹤0.01% 1961
2020
Q2
$58K Hold
3,510
﹤0.01% 1941
2020
Q1
$45K Sell
3,510
-1,055
-23% -$17.2K ﹤0.01% 1920
2019
Q4
$84K Buy
+4,565
New +$75.7K ﹤0.01% 1837

Other funds holding ASTH

Panagora Asset Management's ASTH Position: Q4 2021 in Review

Panagora Asset Management sold out of Astrana Health (ASTH) in Q4 2021, closing a stake of 7,303 shares — an estimated $665K sold.

Panagora Asset Management first reported a position in ASTH in Q4 2019 and held it in 8 quarters. The position peaked at $821K in Q2 2021. 149 funds tracked by Wall St. Rank hold ASTH as of Q4 2021.

  • Panagora Asset Management reported no remaining Astrana Health position as of Q4 2021 after selling out during the quarter.
  • Panagora Asset Management sold 7,303 Astrana Health shares in Q4 2021, an estimated $665K.
  • Panagora Asset Management first reported a position in Astrana Health in Q4 2019 and held it in 8 quarters.
  • Panagora Asset Management's Astrana Health position peaked at $821K in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Astrana Health as of Q4 2021.

Based on Panagora Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.